You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

MONUROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Monurol patents expire, and what generic alternatives are available?

Monurol is a drug marketed by Zambon Spa and is included in one NDA.

The generic ingredient in MONUROL is fosfomycin tromethamine. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fosfomycin tromethamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Monurol

A generic version of MONUROL was approved as fosfomycin tromethamine by XIROMED on October 6th, 2020.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MONUROL?
  • What are the global sales for MONUROL?
  • What is Average Wholesale Price for MONUROL?
Summary for MONUROL
Drug patent expirations by year for MONUROL
Drug Prices for MONUROL

See drug prices for MONUROL

Recent Clinical Trials for MONUROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gerencia de AtenciĆ³n Primaria, MadridPhase 4
Jordi Gol i Gurina FoundationPhase 4
Balearic Islands Health Service (Ibsalut)Phase 4

See all MONUROL clinical trials

US Patents and Regulatory Information for MONUROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zambon Spa MONUROL fosfomycin tromethamine FOR SOLUTION;ORAL 050717-001 Dec 19, 1996 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.